drugset

drugset / Trial / NCT02040987

AZD3293 Thorough QT Study in Healthy Male Volunteers

NCT02040987 ↗

Phase 1 Completed 52 enrolled AstraZeneca Parexel · collab

RandomizedCrossoverDouble-blindBasic science

Summary

A thorough QT study of AZD3293

Timeline

Start: 2014-01
Primary completion: 2014-05
Completion: 2014-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lanabecestat	Small molecule	—	Oral
Comparator	Moxifloxacin	Small molecule	—	—

Indications